Study Group: Experts on Pay-for-Performance Plans
Council Members in this Study Group: 196
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Carrie Harris-Muller, MBA, MHA
Chief Administrative Officer
KAISER FOUNDATION HOSPITALS INC
Carrie Harris-Muller is the Chief Administrative Officer of Kaiser Permanente in the Mid-Atlantic States. Previously, Ms. Harris-Muller served as the Regional Vice President of HealthPlan Administration and Contracting. She has held several executive leadership positions in healthcare, including Cigna...
Dea Belazi, PharmD, MPH, PAHMPharmacy Consultant
Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...
Bruce FriedPartner
SONNENSCHEIN, NATH & ROSENTHAL, LLP
Bruce Merlin Fried is a Partner in the Washington, DC office of Sonnenschein, Nath & Rosenthal. He is a health care law and policy expert who counsels and represents health plans and insurers, physician organizations, hospital groups, health care information technology and data companies, pharmaceutical...
Frederic GoldsteinPresident and Chief Operating Officer
U.S. Preventive Medicine, Inc.Frederic Goldstein, MS, is the President and Chief Operating Officer of U.S. Preventive Medicine, since January 2008. Mr. Goldstein joined USPM when Specialty Disease Management Services which he founded and served as President was acquired by USPM in October of 2007. He has expertise in disease management,...
GLG NewsSM Analyses by this Study Group's Leading Experts (?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Lurasidone will be an important new option for the treatment of Schizophrenia
August 29, 2009
LURASIDONE DEMONSTRATED EFFICACY IN TREATING PATIENTS WITH SCHIZOPHRENIA IN PIVOTAL PHASE 3 STUDY | www.pipelinereview.com
After much disappointment over the current Atypical Antipsychotics , Lurasidone shows great promise for treatment refractory Schizophrenics.
-
New Treatment Option for the Hearing Impaired
August 22, 2009
Oticon Medical Receives FDA Clearance To Market Innovative Bone Anchored Hearing System | www.medicalnewstoday.com
Oticon's new bone anchored hearing implant might offer unique advantages to the hearing impaired.
-
Treatment of Social Anxiety Disorderved
August 6, 2009
NeuroSearch successfully advances NSD-721 for treatment of social anxiety disorder and receives EUR 5 million in equity financing under the alliance with GlaxoSmithKline | www.pipelinereview.com
NeuroSearch new drug NSD-721 will be of great benefit to patients with Social Anxiety Disorder.
-
Is this the end of Bifeprunoxyndrome.
August 3, 2009
Lundbeck, Solvay discontinue all joint R&D activities for bifeprunox to treat schizophrenia | www.pharmabiz.com
Bifeprunox initially looked like it might be a blockbuster for Solvoy when it was first studied.
-
Naproxen and Alzheimer'Alzheimer's/s
July 18, 2009
Naproxen May Help Prevent Alzheimer's | www.webmd.com
We have been searching for a new class of drugs that will show true promise for Alzheimer's Dementia.
Members in this Study Group include these company types:
- Managed Care Health Insurer, For-Profit
- Office Based Private Practice or Clinic
- Managed Care Health Insurer, Non-Profit
- Academic Medical Center/Hospital or Clinic
- Blue Cross/Blue Shield Non-Profit Health Insurer
- Consultancy, Healthcare-Focused
- Other Health Insurer, For-Profit
- Integrated Healthcare Delivery Network (IDN)
- Third Party Administrator
Members in this Study Group often have these job titles:
- Director
- Physician - Attending Physician
- Medical Director
- Pharmacist - RPh/PharmD
- Owner
- Consultant
- President
- Chief Executive Officer
- Operations Executive
- Chief Medical Officer
- Manager
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Medicare Experts | 495 |
| Managed Care Experts | 670 |
| Economic Experts on Managed Care | 716 |
| Managed Care Pricing Trends Experts | 281 |
| Formulary Design Experts | 252 |
| Generic Drug Economic Experts | 767 |
| Pharmacists (US) | 2079 |